|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3 SEK | -2.60% |
|
-3.54% | -65.91% |
| Apr. 09 | Biosergen to Issue New Units as Compensation Under Rights Issue | MT |
| Mar. 27 | Biosergen Raises SEK26.4 Million via Rights Issue | MT |
Biosergen AB reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue was SEK 5.32 million compared to SEK 1.32 million a year ago. Net loss was SEK 5.03 million compared to SEK 5.02 million a year ago.
Basic loss per share from continuing operations was SEK 0.18 compared to SEK 0.18 a year ago. Diluted loss per share from continuing operations was SEK 0.18 compared to SEK 0.18 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -65.91% | 4.05M | |
| +7.52% | 111B | |
| +11.38% | 106B | |
| -12.64% | 22.24B | |
| +0.44% | 21.25B | |
| -4.18% | 18.97B | |
| -37.85% | 18.52B | |
| -8.58% | 16.81B | |
| +37.41% | 12.54B | |
| -23.95% | 8.09B |
BIOSERGEN AB 
